AI-driven precision medicine for oncology and rare genetic disorders!
Based in Switzerland.
SOPHiA GENETICS is a global healthcare technology company focused on advancing precision medicine through artificial intelligence and cloud-based analytics. Its solutions help laboratories, clinicians, and healthcare institutions turn complex genomic data into actionable insights for patients with cancer and rare or inherited disorders.
At the core of its portfolio is the SOPHiA DDM™ Platform, an AI-powered platform designed to analyze next-generation sequencing data and support precision medicine workflows. The company also offers advanced tools for variant interpretation, including Alamut™ Visual Plus.
SOPHiA GENETICS supports healthcare providers by helping streamline genomic workflows, improve interpretation efficiency, and support faster clinical decision-making, while maintaining strong standards for data privacy, security, and regulatory compliance.
Its solutions serve key areas including oncology, rare and inherited diseases, and BioPharma, supporting more effective genomic analysis and broader adoption of precision diagnostics.
